Costs Associated with Angiogenesis Inhibitor Therapies for Metastatic Renal Cell Carcinoma in Clinical Practice: Results from A Medical Chart Review Study

Urol Oncol. 2010 Oct 4

View abstract

Authors

Choueiri T, McDermott D, Duh M, Antras L, Chen K, Sarda S, Luka A, Neary M, Oh W